dicyandiamido has been researched along with Ovarian Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bair, KW; Baumeister, T; Buckmelter, AJ; Caligiuri, M; Clodfelter, KH; Dragovich, PS; Han, B; Ho, YC; Kley, N; Lin, J; Oh, A; Reynolds, DJ; Sharma, G; Smith, CC; Wang, W; Wang, Y; Wang, Z; Yuen, PW; Zak, M; Zheng, X | 1 |
1 other study(ies) available for dicyandiamido and Ovarian Neoplasms
Article | Year |
---|---|
Discovery of potent and efficacious cyanoguanidine-containing nicotinamide phosphoribosyltransferase (Nampt) inhibitors.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Cytokines; Dose-Response Relationship, Drug; Drug Discovery; Enzyme Inhibitors; Female; Guanidines; Humans; Mice; Models, Molecular; Molecular Structure; Neoplasms, Experimental; Nicotinamide Phosphoribosyltransferase; Ovarian Neoplasms; Structure-Activity Relationship; Xenograft Model Antitumor Assays | 2014 |